We are live on ! Find out more
ACM

Asymmetry Capital Management Portfolio holdings

AUM $188M
1-Year Est. Return 44.72%
This Fund
S&P 500
This Quarter Est. Return
+16.13%
1 Year Est. Return
+44.72%
3 Year Est. Return
+299.95%
5 Year Est. Return
+628.83%
10 Year Est. Return
–
AUM
$79.9M
AUM Growth
+$6.27M
Cap. Flow
-$2.71M
Cap. Flow %
-3.39%
Top 10 Hldgs %
57.13%
Holding
44
New
13
Increased
11
Reduced
12
Closed
8

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$1.93M
2
KALA icon
KALA BIO
KALA
+$1.86M
3
BSX icon
Boston Scientific
BSX
+$1.86M
4
LJPC
La Jolla Pharmaceutical Company
LJPC
+$1.8M
5
AERI
Aerie Pharmaceuticals
AERI
+$1.64M

Top Sells

Rank Stock Value
1
PTCT icon
PTC Therapeutics
PTCT
+$5.88M
2
DGX icon
Quest Diagnostics
DGX
+$3.21M
3
BIO icon
Bio-Rad Laboratories Class A
BIO
+$2.36M
4
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$2.01M
5
NVTA
Invitae Corporation
NVTA
+$1.97M

Sector Composition

Rank Sector Weight
1 Healthcare 95.27%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BIO icon
26
Bio-Rad Laboratories Class A
BIO
$9.42B
$1.13M 1.41%
4,511
-9,283
-67% -$2.36M
GBT
27
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.06M 1.33%
+22,000
New +$1.23M
PRGO icon
28
Perrigo
PRGO
$1.78B
$1.06M 1.33%
12,747
-5,382
-30% -$470K
EXAS
29
DELISTED
Exact Sciences
EXAS
$1.04M 1.3%
+25,803
New +$1.26M
TVTY
30
DELISTED
Tivity Health, Inc. Common Stock
TVTY
$975K 1.22%
+24,601
New +$955K
KDMN
31
DELISTED
Kadmon Holdings, Inc.
KDMN
$846K 1.06%
+199,147
New +$852K
ECYT
32
DELISTED
Endocyte, Inc. Common Stock
ECYT
$831K 1.04%
91,435
+9,951
+12% +$54.9K
NCNA
33
NuCana
NCNA
$6.12M
$765K 0.96%
+8
New +$760K
RGNX icon
34
Regenxbio
RGNX
$708M
$478K 0.6%
+16,008
New +$466K
OPK icon
35
Opko Health
OPK
$1.02B
$447K 0.56%
+141,044
New +$568K
MTEM
36
DELISTED
Molecular Templates, Inc.
MTEM
$14K 0.02%
+113
New +$17K
BMRN icon
37
BioMarin Pharmaceuticals
BMRN
$12.4B
– –
-10,733
Closed -$957K
TARA icon
38
Protara Therapeutics
TARA
$232M
– –
-235
Closed -$18K
TEVA icon
39
Teva Pharmaceuticals
TEVA
$41.2B
– –
-69,124
Closed -$1.31M
NVTA
40
DELISTED
Invitae Corporation
NVTA
– –
-216,687
Closed -$1.97M
ADMS
41
DELISTED
Adamas Pharmaceuticals
ADMS
– –
-25,311
Closed -$858K
SNNA
42
DELISTED
Sienna Biopharmaceuticals, Inc.
SNNA
– –
-26,692
Closed -$484K
ALDR
43
DELISTED
Alder Biopharmaceuticals
ALDR
– –
-92,518
Closed -$1.06M
SGYP
44
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
– –
-477,621
Closed -$1.06M
1
2

Similar funds

FAC
Forrestal Agricultural Corporation Princeton, New Jersey $183M AUM
SWM
Strategic Wealth Management Kirkland, Washington $202M AUM 9.35% 1-Year Est. Return
MC
MRJ Capital New York $173M AUM 31.99% 1-Year Est. Return
KM
Kylin Management New York $173M AUM 39.51% 1-Year Est. Return
TI
Truehand Inc Strafford, New Hampshire $171M AUM 25.9% 1-Year Est. Return
GC
Grace Capital Quincy, Massachusetts $168M AUM 21.6% 1-Year Est. Return
REMS
Real Estate Management Services $167M AUM 37.69% 1-Year Est. Return
NM
Nokota Management New York $165M AUM

Asymmetry Capital Management's Q1 2018 Portfolio in Review

As of Q1 2018, Asymmetry Capital Management held 44 positions worth $79.9M, up 8.5% from $73.7M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

Asymmetry Capital Management withdrew a net $2.71M in Q1 2018, closing 8 positions and reducing 12 holdings. Its most notable exit was Invitae Corporation, an estimated $1.97M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 95% of assets, up from 93% a quarter earlier.

Against the trend, Asymmetry Capital Management opened a new position in Pfizer worth $1.89M.

  • Asymmetry Capital Management's largest Q1 2018 buy was Pfizer: 56,117 shares worth $1.89M.
  • Asymmetry Capital Management added most to KALA BIO in Q1 2018, an estimated $1.86M increase.
  • Asymmetry Capital Management's biggest Q1 2018 reduction was PTC Therapeutics, cutting an estimated $5.88M.
  • Asymmetry Capital Management fully exited Invitae Corporation in Q1 2018, selling an estimated $1.97M.
  • Asymmetry Capital Management's ten largest holdings make up 57% of its $79.9M portfolio in Q1 2018.
  • Asymmetry Capital Management opened 13 new positions and closed 8 in Q1 2018.
  • Asymmetry Capital Management's portfolio value rose 8.5% quarter-over-quarter to $79.9M.

Based on Asymmetry Capital Management's 13F filing for Q1 2018, filed 9 May 2018.